Kovacs G R, Moss B
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.
J Virol. 1996 Oct;70(10):6796-802. doi: 10.1128/JVI.70.10.6796-6802.1996.
The vaccinia virus late stage-specific transcription factor P3 was purified to homogeneity from HeLa cells that were infected in the presence of an inhibitor of viral DNA replication. The purified 36-kDa protein was digested with trypsin, and the peptides were analyzed by mass spectroscopy and amino-terminal sequencing. The purified factor was identified as the product of the vaccinia virus H5R open reading frame by both methods. A recombinant baculovirus was engineered to express the H5R open reading frame. The partially purified recombinant protein could replace the vaccinia virus P3 factor in transcription assays. On the basis of these findings, we assigned the H5R gene product the name viral late gene transcription factor 4 (VLTF-4). Unlike VLTF-1, -2, and -3, which are synthesized exclusively after viral DNA replication, VLTF-4 is synthesized before and after viral DNA synthesis. Indirect immunofluorescence of infected cells with anti-H5R protein antiserum demonstrated that VLTF-4 is diffusely distributed in the cytoplasm when DNA replication is blocked but is localized to discrete viral DNA-containing factories during a productive infection. Its expression pattern and subcellular distribution suggest that the H5R gene product may have multiple roles in the viral life cycle.
痘苗病毒晚期特异性转录因子P3是从在病毒DNA复制抑制剂存在下感染的HeLa细胞中纯化至同质的。纯化的36 kDa蛋白用胰蛋白酶消化,肽段通过质谱和氨基末端测序进行分析。两种方法均将纯化的因子鉴定为痘苗病毒H5R开放阅读框的产物。构建了一种重组杆状病毒以表达H5R开放阅读框。部分纯化的重组蛋白在转录试验中可替代痘苗病毒P3因子。基于这些发现,我们将H5R基因产物命名为病毒晚期基因转录因子4(VLTF-4)。与仅在病毒DNA复制后合成的VLTF-1、-2和-3不同,VLTF-4在病毒DNA合成之前和之后均有合成。用抗H5R蛋白抗血清对感染细胞进行间接免疫荧光显示,当DNA复制受阻时,VLTF-4在细胞质中呈弥散分布,但在生产性感染期间定位于离散的含病毒DNA的工厂。其表达模式和亚细胞分布表明,H5R基因产物可能在病毒生命周期中具有多种作用。